Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Integrated Viral Hepatitis Surveillance and Prevention Funding for New York State Department of Health (NYSDOH)

Award Number: NU51PS005186
ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES
OPDIV: CDC
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 05/01/2021
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

Integrated Viral Hepatitis Surveillance and Prevention Funding for New York State Department of Health (NYSDOH) - Viral hepatitis, mainly HAV, HBV and HCV are serious and growing threats to the health of Americans, including New Yorkers. According to the Centers for Disease Control and Prevention, in the United States, 860,000 people are living with HBV, 2.4 million people are living with HCV, and almost 25,000 cases of HAV were reported in 2018.(1) New York State (NYS), outside of New York City, has one of the highest burdens related to viral hepatitis in the country. In 2018, NYS had the second highest case count of chronic HBV in the country and is among the five states with highest case counts for chronic HCV in the nation with approximately 8,000 cases.(2) Viral hepatitis infections, HBV and HCV in particular, increase individuals’ risk of liver disease and cancer, increasing the cost of health care and death rates. Additionally, of concern is the increase of new infections of HCV among women of childbearing age, persons experiencing homelessness, and that can be linked to injection drug use and the growing opioid epidemic across our nation. HAV and HBV are vaccine preventable diseases, and the approval of direct acting antiviral therapies has made eliminating HCV a possibility. However, many people with HBV and HCV are unaware they are infected. To address these issues, complete diagnostic testing, vaccination when available, appropriate linkage to care and treatment by addressing gaps in care cascades and addressing appropriately social determinants of health for these individuals is critical to reduce the impact viral hepatitis have on New Yorkers. This is a joint application between the NYS Department of Health (DOH) Division of Epidemiology, HBV and HCV Surveillance Program, whose responsibility is viral hepatitis surveillance activities and policy development, and the AIDS Institute, Bureau of Hepatitis Health Care, whose responsibilities include HCV prevention, care, treatment and policy-related activities. Both programs work collaboratively to prevent new viral hepatitis infections, limit morbidity and mortality, and to eliminate HCV in NYS. Under CDC- RFA-PS21-2103, NYSDOH is requesting $951,049 ($491,308 for Component 1 and $459,741 for Component 2). Interventions under Component 1, include a) developing plans, processes, data systems and policy interventions for viral hepatitis -HAV, HBV, and HCV- early outbreak detection and outbreak response; b) improve data collection systems, data quality and completeness, enhance surveillance capacity, including improving laboratory reporting and case investigation, to characterize trends, disease burden, and inform public health interventions for HAV, acute and chronic HBV, acute and chronic HCV, and perinatal HCV. All interventions will be aimed at the population level with a focus on persons under 45 years of age, women in childbearing age, and persons who inject drugs (PWID). For component 2, the target population is PWID and the high impact settings are syringe service programs (SSPs), substance use treatment programs and correctional facilities. The goals are 1) increase HCV testing across substance use treatment programs; 2) increase awareness of HCV status among PWID; 3) increase referral for HCV treatment among PWID diagnosed with HCV; and 4) increase hepatitis A and B vaccine among PWID. These goals will be achieved by developing a data-to-care model using existing data sources, including the HCV surveillance data and additional data from high impact settings; and by increasing SSP capacity to administer hepatitis A and B vaccinations. (1) Centers for Disease Control and Prevention, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, https://www.cdc.gov/hepatitis/index.htm (2) Centers for Disease Control and Prevention, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention https://www.cdc.gov/hepatitis/statistics/2018surveillance/pdfs/2018HepSurveillanceRpt.pdf


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $315,000 )
2026	2026	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	5	4/27/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$315,000
2026	2025	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	5	11/13/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2025	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	5	4/27/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2024	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	5	4/27/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2024	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	5	11/13/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	5	4/27/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	5	11/13/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	5	4/27/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	5	11/13/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	5	11/13/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2026	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	5	4/27/2026	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $315,000

Issue Date FY: 2025 ( Subtotal = $315,000 )
2025	2025	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	5	4/30/2025	NON-COMPETING CONTINUATION	$315,000
2025	2024	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	5	4/30/2025	NON-COMPETING CONTINUATION	$0
2025	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	5	4/30/2025	NON-COMPETING CONTINUATION	$0
2025	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	5	4/30/2025	NON-COMPETING CONTINUATION	$0
2025	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	5	4/30/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $315,000

Issue Date FY: 2024 ( Subtotal = $315,000 )
2024	2024	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$315,000
2024	2024	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	4	7/22/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	3	10/30/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	4	7/22/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$0
2024	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	4	7/22/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	3	10/30/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$0
2024	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	3	10/30/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	4	7/22/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	4	4/19/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $315,000

Issue Date FY: 2023 ( Subtotal = $315,000 )
2023	2023	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	3	4/6/2023	NON-COMPETING CONTINUATION	$315,000
2023	2022	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	3	4/6/2023	NON-COMPETING CONTINUATION	$0
2023	2022	HEALTH RESEARCH, INC.	150 BROADWAY STE 560	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	2	12/9/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2021	HEALTH RESEARCH, INC.	150 BROADWAY STE 560	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	02	2	12/9/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2021	HEALTH RESEARCH, INC.	150 BROADWAY, SUITE 280	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	3	4/6/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $315,000

Issue Date FY: 2022 ( Subtotal = $315,000 )
2022	2022	HEALTH RESEARCH, INC.	150 Broadway STE 560	Menands	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	2	8/25/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2022	HEALTH RESEARCH, INC.	150 BROADWAY STE 560	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	2	4/20/2022	NON-COMPETING CONTINUATION	$315,000
2022	2021	HEALTH RESEARCH, INC.	150 Broadway STE 560	Menands	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	2	8/25/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $315,000

Issue Date FY: 2021 ( Subtotal = $315,000 )
2021	2021	HEALTH RESEARCH, INC.	150 BROADWAY STE 560	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	01	1	6/16/2021	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2021	2021	HEALTH RESEARCH, INC.	150 BROADWAY STE 560	MENANDS	NY	12204	ALBANY	USA	Viral Hepatitis Prevention and Control	00	1	4/21/2021	NEW	$315,000
														Subtotal = $315,000

Grand Total All Awards = $1,890,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Integrated Viral Hepatitis Surveillance and Prevention Funding for New York State Department of Health (NYSDOH)

Award Number: NU51PS005186

ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES

OPDIV: CDC

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 05/01/2021

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer